Firmenbeschreibung
Intuitive Surgical, Inc. ist ein US-amerikanisches Medizintechnikunternehmen. Der Konzern gehört zu den führenden Anbietern von Robotersystemen, die innerhalb der minimal invasiven Chirurgie (MIS) eingesetzt werden. Kernprodukt des Unternehmens ist das sogenannte da Vinci®-System. Das eigens von Intuitive Surgical entwickelte Produkt wird sowohl bei Eingriffen im Thoraxbereich oder am Herzen als auch in der Urologie und Gynäkologie verwendet. Das System besteht aus einer Operationskonsole, einem hochauflösenden Bildschirmsystem mit 3D-Virtualisierung sowie patentierten Instrumenten. So bietet die Apparatur dem Benutzer die Möglichkeit, selbst schwierige Eingriffe und Operationen bei nur geringer Inzision noch präziser durchführen zu können. Zu den Kunden des Unternehmens gehören in erster Linie Krankenhäuser, außerdem wird das da Vinci®-System auch innerhalb des Militärs eingesetzt. Unter dem Dach der Intuitive Surgical, Inc. entwickeln und produzieren zahlreiche Tochterfirmen verschiedenartige Produkte, die innerhalb der operativen Medizin gebraucht werden. Die Tochtergesellschaften vertreiben die jeweiligen Produkte unter eigenem Markennamen. Hierzu gehören unter anderem: EndoWrist, da Vinci®-Si oder Single-Site. Außerdem arbeitet der Konzern mit verschiedenen anderen Unternehmen und Forschungszentren zusammen, um den technischen Standard seiner Produkte verbessern zu können. Das Unternehmen kooperiert mit dem Massachusetts Institute of Technology (MIT), Power Medical Interventions, InTouch Health und der John Hopkins Universität.
KeyData
endOfFinancialYear: | 31.12.2022 00:00 |
stockholderStructure: | Freefloat (77.9%),The Vanguard Group, Inc. (7.8%),BlackRock, Inc. (7.4%),T. Rowe Price Associates, Inc. (6.9%) |
sharesOutstanding: | 350398068.0000 |
ceo: | Dr. Gary S. Guthart |
board: | Jamie Samath, Bob DeSantis, Craig Child, Dave J. Rosa, Dr. Brian Miller, Dr. Chris Carlson, Gillian Duncan, Glenn Vavoso, Henry Charlton, Julian Nikolchec, Kara Andersen Reiter, Lesly Marban, Mark Johnson, Marshall L. Mohr, Myriam J. Curet |
supervisoryBoard: | Dr. Craig H. Barratt, Amal M. Johnson, Amy L. Ladd, M.D., Dr. Alan J. Levy, Dr. Don Kania, Dr. Gary S. Guthart, Jami Dover Nachtsheim, Joseph C. Beery, Keith R. Leonard, Jr., Mark J. Rubash, Monica P. Reed, M.D. |
countryID: | 20 |
freeFloat: | 77.9000 |
faceValue: | 0.0010 |
faceValueCurrencyID: | 4 |
faceValueCurrency: | USD |
sectorName: | Medizintechnische Produkte |
industryName: | Gesundheitswesen |
subsectorName: | Hochentwickelte medizinische Geräte |
country: | USA |
countryName: | USA |
Kontakt
phone: | +1-408-523-2161 |
email: | investor.relations@intusurg.com |
irWebSite: | goo.gl/W5uRbZ |
Adresse
street: | 1020 Kifer Road, Building 101 |
city: | Sunnyvale, California 94086-5304, USA |
phone: | +1-408-523-2100 |
fax: | +1-408-523-1390 |
webSite: | www.intuitivesurgical.com |
Finanzen (kurz)
year: | 2020 | cash: | 1622.6000 |
balanceSheetTotal: | 11168.9000 | liabilities: | 1409.8000 |
totalShareholdersEquity: | 9759.1000 | sales: | 4358.4000 |
investment: | 0.0000 | incomeBeforeTaxes: | 1207.0000 |
netIncome: | 1060.6000 | cashFlow: | 455.9000 |
employees: | 8081 | currencyID: | 4 |
units: | 1000000 | currency: | USD |
year: | 2021 | cash: | 1290.9000 |
balanceSheetTotal: | 13555.0000 | liabilities: | 1603.5000 |
totalShareholdersEquity: | 11951.5000 | sales: | 5710.1000 |
investment: | 0.0000 | incomeBeforeTaxes: | 1890.3000 |
netIncome: | 1704.6000 | cashFlow: | -332.5000 |
employees: | 9793 | currencyID: | 4 |
units: | 1000000 | currency: | USD |
year: | 2022 | cash: | 1581.2000 |
balanceSheetTotal: | 12974.0000 | liabilities: | 1861.4000 |
totalShareholdersEquity: | 11112.6000 | sales: | 6222.2000 |
incomeBeforeTaxes: | 1606.8000 | netIncome: | 1322.3000 |
cashFlow: | 294.7000 | currencyID: | 4 |
units: | 1000000 | currency: | USD |
Finanzen (kurz)
year: | 2020 |
cash: | 1622.6000 |
balanceSheetTotal: | 11168.9000 |
liabilities: | 1409.8000 |
totalShareholdersEquity: | 9759.1000 |
sales: | 4358.4000 |
investment: | 0.0000 |
incomeBeforeTaxes: | 1207.0000 |
netIncome: | 1060.6000 |
cashFlow: | 455.9000 |
employees: | 8081 |
currencyID: | 4 |
units: | 1000000 |
currency: | USD |
year: | 2021 |
cash: | 1290.9000 |
balanceSheetTotal: | 13555.0000 |
liabilities: | 1603.5000 |
totalShareholdersEquity: | 11951.5000 |
sales: | 5710.1000 |
investment: | 0.0000 |
incomeBeforeTaxes: | 1890.3000 |
netIncome: | 1704.6000 |
cashFlow: | -332.5000 |
employees: | 9793 |
currencyID: | 4 |
units: | 1000000 |
currency: | USD |
year: | 2022 |
cash: | 1581.2000 |
balanceSheetTotal: | 12974.0000 |
liabilities: | 1861.4000 |
totalShareholdersEquity: | 11112.6000 |
sales: | 6222.2000 |
incomeBeforeTaxes: | 1606.8000 |
netIncome: | 1322.3000 |
cashFlow: | 294.7000 |
currencyID: | 4 |
units: | 1000000 |
currency: | USD |
Finanzen (ausführlich)
year: | 2021 | units: | 1000000 |
balanceSheetTotal: | 13555.0000 | cash: | 1290.9000 |
currentAssets: | 5844.9000 | fixedAssets: | 7710.1000 |
liabilities: | 1149.8000 | nonCurrentLiabilities: | 453.7000 |
totalLiabilitiesEquity: | 13555.0000 | totalShareholdersEquity: | 11951.5000 |
employees: | 9793 | property: | 1876.4000 |
longTermInvestments: | 4415.5000 | inventories: | 587.1000 |
accountsReceivable: | 782.7000 | accountsPayable: | 121.2000 |
liabilitiesTotal: | 1603.5000 | minorityInterests: | 50.4000 |
sales: | 5710.1000 | depreciation: | 310.2000 |
netIncome: | 1704.6000 | operatingResult: | 1821.0000 |
incomeInterest: | 69.3000 | investments: | 671.0000 |
incomeTaxes: | 162.2000 | costGoodsSold: | 1751.6000 |
grossProfit: | 3958.5000 | minorityInterestsProfit: | 23.5000 |
revenuePerEmployee: | 583079.7508 | cashFlow: | 2089.4000 |
cashFlowInvesting: | -2461.5000 | cashFlowFinancing: | 43.0000 |
cashFlowTotal: | -332.5000 | accountingStandard: | US GAAP |
equityRatio: | 88.1704 | debtEquityRatio: | 13.4167 |
liquidityI: | 112.2717 | liquidityII: | 180.3444 |
netMargin: | 29.8524 | grossMargin: | 69.3245 |
cashFlowMargin: | 36.5913 | ebitMargin: | 31.8909 |
ebitdaMargin: | 0.0000 | preTaxROE: | 15.8164 |
preTaxROA: | 13.9454 | roe: | 14.2626 |
roa: | 12.5754 | netIncomeGrowth: | 60.7203 |
revenuesGrowth: | 31.0137 | taxExpenseRate: | 8.5806 |
equityTurnover: | 0.4778 | epsBasic: | 4.7900 |
epsDiluted: | 4.6600 | epsBasicGrowth: | 58.6093 |
incomeBeforeTaxes: | 1890.3000 | priceEarningsRatioCompany: | 75.0104 |
priceCashFlowRatio: | 61.5188 | bookValuePerShare: | 33.4080 |
marketCap: | 128537430338.3000 | earningsYield: | 1.3331 |
pegRatio: | 1.2798 | cashFlowPerShare: | 5.8405 |
netAssetsPerShare: | 33.5488 | priceBookValueRatio: | 10.7549 |
priceEarningsRatio: | 75.4062 | netEarningsPerShare: | 4.7649 |
currency: | USD |
year: | 2022 | units: | 1000000 |
balanceSheetTotal: | 12974.0000 | cash: | 1581.2000 |
currentAssets: | 6253.0000 | fixedAssets: | 6721.0000 |
liabilities: | 1422.1000 | totalLiabilitiesEquity: | 12974.0000 |
totalShareholdersEquity: | 11112.6000 | property: | 2374.2000 |
longTermInvestments: | 2623.6000 | inventories: | 893.2000 |
accountsReceivable: | 942.1000 | accountsPayable: | 147.0000 |
liabilitiesTotal: | 1861.4000 | minorityInterests: | 70.7000 |
sales: | 6222.2000 | depreciation: | 365.8000 |
netIncome: | 1322.3000 | operatingResult: | 1577.1000 |
incomeInterest: | 29.7000 | investments: | 879.0000 |
incomeTaxes: | 262.4000 | costGoodsSold: | 2026.2000 |
grossProfit: | 4196.0000 | minorityInterestsProfit: | 22.1000 |
cashFlow: | 1490.8000 | cashFlowInvesting: | 1370.8000 |
cashFlowFinancing: | -2572.3000 | cashFlowTotal: | 294.7000 |
accountingStandard: | US GAAP | equityRatio: | 85.6528 |
debtEquityRatio: | 16.7504 | liquidityI: | 111.1877 |
liquidityII: | 177.4348 | netMargin: | 21.2513 |
grossMargin: | 67.4360 | cashFlowMargin: | 23.9594 |
ebitMargin: | 25.3463 | ebitdaMargin: | 0.0000 |
preTaxROE: | 14.4593 | preTaxROA: | 12.3848 |
roe: | 11.8991 | roa: | 10.1919 |
netIncomeGrowth: | -22.4275 | revenuesGrowth: | 8.9683 |
taxExpenseRate: | 16.3306 | equityTurnover: | 0.5599 |
epsBasic: | 3.7200 | epsDiluted: | 3.6500 |
epsBasicGrowth: | -22.3382 | incomeBeforeTaxes: | 1606.8000 |
priceEarningsRatioCompany: | 71.3306 | priceCashFlowRatio: | 62.3664 |
bookValuePerShare: | 31.7150 | marketCap: | 92975901322.6500 |
earningsYield: | 1.4019 | pegRatio: | -3.1932 |
cashFlowPerShare: | 4.2547 | netAssetsPerShare: | 31.9168 |
priceBookValueRatio: | 8.3667 | priceEarningsRatio: | 70.3138 |
netEarningsPerShare: | 3.7738 | currency: | USD |
year: | 2023 | priceEarningsRatioCompany: | 84.0753 |
priceCashFlowRatio: | 73.5094 | bookValuePerShare: | 31.7150 |
marketCap: | 109590499747.6800 | earningsYield: | 1.1894 |
pegRatio: | -3.7637 | cashFlowPerShare: | 4.2547 |
netAssetsPerShare: | 31.7150 | priceBookValueRatio: | 9.8616 |
priceEarningsRatio: | 82.8767 | netEarningsPerShare: | 3.7738 |
currency: | USD |
Finanzen (ausführlich)
year: | 2021 |
units: | 1000000 |
balanceSheetTotal: | 13555.0000 |
cash: | 1290.9000 |
currentAssets: | 5844.9000 |
fixedAssets: | 7710.1000 |
liabilities: | 1149.8000 |
nonCurrentLiabilities: | 453.7000 |
totalLiabilitiesEquity: | 13555.0000 |
totalShareholdersEquity: | 11951.5000 |
employees: | 9793 |
property: | 1876.4000 |
longTermInvestments: | 4415.5000 |
inventories: | 587.1000 |
accountsReceivable: | 782.7000 |
accountsPayable: | 121.2000 |
liabilitiesTotal: | 1603.5000 |
minorityInterests: | 50.4000 |
sales: | 5710.1000 |
depreciation: | 310.2000 |
netIncome: | 1704.6000 |
operatingResult: | 1821.0000 |
incomeInterest: | 69.3000 |
investments: | 671.0000 |
incomeTaxes: | 162.2000 |
costGoodsSold: | 1751.6000 |
grossProfit: | 3958.5000 |
minorityInterestsProfit: | 23.5000 |
revenuePerEmployee: | 583079.7508 |
cashFlow: | 2089.4000 |
cashFlowInvesting: | -2461.5000 |
cashFlowFinancing: | 43.0000 |
cashFlowTotal: | -332.5000 |
accountingStandard: | US GAAP |
equityRatio: | 88.1704 |
debtEquityRatio: | 13.4167 |
liquidityI: | 112.2717 |
liquidityII: | 180.3444 |
netMargin: | 29.8524 |
grossMargin: | 69.3245 |
cashFlowMargin: | 36.5913 |
ebitMargin: | 31.8909 |
ebitdaMargin: | 0.0000 |
preTaxROE: | 15.8164 |
preTaxROA: | 13.9454 |
roe: | 14.2626 |
roa: | 12.5754 |
netIncomeGrowth: | 60.7203 |
revenuesGrowth: | 31.0137 |
taxExpenseRate: | 8.5806 |
equityTurnover: | 0.4778 |
epsBasic: | 4.7900 |
epsDiluted: | 4.6600 |
epsBasicGrowth: | 58.6093 |
incomeBeforeTaxes: | 1890.3000 |
priceEarningsRatioCompany: | 75.0104 |
priceCashFlowRatio: | 61.5188 |
bookValuePerShare: | 33.4080 |
marketCap: | 128537430338.3000 |
earningsYield: | 1.3331 |
pegRatio: | 1.2798 |
cashFlowPerShare: | 5.8405 |
netAssetsPerShare: | 33.5488 |
priceBookValueRatio: | 10.7549 |
priceEarningsRatio: | 75.4062 |
netEarningsPerShare: | 4.7649 |
currency: | USD |
year: | 2022 |
units: | 1000000 |
balanceSheetTotal: | 12974.0000 |
cash: | 1581.2000 |
currentAssets: | 6253.0000 |
fixedAssets: | 6721.0000 |
liabilities: | 1422.1000 |
totalLiabilitiesEquity: | 12974.0000 |
totalShareholdersEquity: | 11112.6000 |
property: | 2374.2000 |
longTermInvestments: | 2623.6000 |
inventories: | 893.2000 |
accountsReceivable: | 942.1000 |
accountsPayable: | 147.0000 |
liabilitiesTotal: | 1861.4000 |
minorityInterests: | 70.7000 |
sales: | 6222.2000 |
depreciation: | 365.8000 |
netIncome: | 1322.3000 |
operatingResult: | 1577.1000 |
incomeInterest: | 29.7000 |
investments: | 879.0000 |
incomeTaxes: | 262.4000 |
costGoodsSold: | 2026.2000 |
grossProfit: | 4196.0000 |
minorityInterestsProfit: | 22.1000 |
cashFlow: | 1490.8000 |
cashFlowInvesting: | 1370.8000 |
cashFlowFinancing: | -2572.3000 |
cashFlowTotal: | 294.7000 |
accountingStandard: | US GAAP |
equityRatio: | 85.6528 |
debtEquityRatio: | 16.7504 |
liquidityI: | 111.1877 |
liquidityII: | 177.4348 |
netMargin: | 21.2513 |
grossMargin: | 67.4360 |
cashFlowMargin: | 23.9594 |
ebitMargin: | 25.3463 |
ebitdaMargin: | 0.0000 |
preTaxROE: | 14.4593 |
preTaxROA: | 12.3848 |
roe: | 11.8991 |
roa: | 10.1919 |
netIncomeGrowth: | -22.4275 |
revenuesGrowth: | 8.9683 |
taxExpenseRate: | 16.3306 |
equityTurnover: | 0.5599 |
epsBasic: | 3.7200 |
epsDiluted: | 3.6500 |
epsBasicGrowth: | -22.3382 |
incomeBeforeTaxes: | 1606.8000 |
priceEarningsRatioCompany: | 71.3306 |
priceCashFlowRatio: | 62.3664 |
bookValuePerShare: | 31.7150 |
marketCap: | 92975901322.6500 |
earningsYield: | 1.4019 |
pegRatio: | -3.1932 |
cashFlowPerShare: | 4.2547 |
netAssetsPerShare: | 31.9168 |
priceBookValueRatio: | 8.3667 |
priceEarningsRatio: | 70.3138 |
netEarningsPerShare: | 3.7738 |
currency: | USD |
year: | 2023 |
priceEarningsRatioCompany: | 84.0753 |
priceCashFlowRatio: | 73.5094 |
bookValuePerShare: | 31.7150 |
marketCap: | 109590499747.6800 |
earningsYield: | 1.1894 |
pegRatio: | -3.7637 |
cashFlowPerShare: | 4.2547 |
netAssetsPerShare: | 31.7150 |
priceBookValueRatio: | 9.8616 |
priceEarningsRatio: | 82.8767 |
netEarningsPerShare: | 3.7738 |
currency: | USD |